Compare HTCR & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HTCR | ISPC |
|---|---|---|
| Founded | 2009 | 2009 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4M | 3.8M |
| IPO Year | 2022 | 2020 |
| Metric | HTCR | ISPC |
|---|---|---|
| Price | $2.65 | $1.67 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 27.8K | ★ 63.2K |
| Earning Date | 05-14-2026 | 05-18-2026 |
| Dividend Yield | ★ 87.84% | N/A |
| EPS Growth | ★ 414.29 | 87.03 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $30,407,229.00 | $1,928,998.00 |
| Revenue This Year | $123.26 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 39.19 | N/A |
| 52 Week Low | $0.15 | $0.10 |
| 52 Week High | $3.97 | $6.77 |
| Indicator | HTCR | ISPC |
|---|---|---|
| Relative Strength Index (RSI) | 52.29 | 34.00 |
| Support Level | $2.43 | $0.25 |
| Resistance Level | $2.91 | $2.38 |
| Average True Range (ATR) | 0.20 | 0.24 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 62.05 | 10.24 |
HeartCore Enterprises Inc is a software development company providing solutions for digital transformation (DX). It develops, sells, and maintains CMS and CXM platforms using digital marketing technology, RPA, process mining solutions, myInvenio and Apromore, task mining solution CONTROLIO, and 3D-VR services including Matterport and VR360. The company also provides management consulting, education, services, and support to help customers succeed with the CXM Platform. It operates through two business units, the CX division for customer experience management and the DX division for digital transformation, which provides robotics process automation, process mining, and task mining. Its products include VR360, myInvenio, Apromore, and others, with maximum revenue from the United States.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.